MUMBAI, India, Nov. 2 -- Intellectual Property India has published a patent application (202611099420 A) filed by Noida International University on August 17, 2026, for Smart Insulin Dose Monitoring Device.
Inventor includes Priyanka Rai.
The application for the patent was published on October 30, 2026, under issue no. 44/2026.
Abstract: The intelligent insulin dose monitoring device that was created to improve the precision and security of insulin delivery is the subject of the current invention. The device is designed to match the selected dose of insulin with the recommended dosage information that is stored in the system before injecting insulin. It includes a processing unit, a dose recognition mechanism, a display device and an alert system to detect the wrong dose selection and to provide timely warning signals. The gadget reduces insulin dosage mistakes such as over or under dosage resulting in significant health problems. It not only helps patients, caregivers, and healthcare providers by keeping dosage records and improving adherence to insulin therapy but also aids in patient education and medication management. The proposed device is compact, portable and easy to use, suitable for in-clinic and home diabetes management. The objectives of this invention are to enhance the confidence of patients, improve the safety of the medicine given to the patient and improve the diabetic care outcomes.
Disclaimer: Curated by HT Syndication.
